Nelson B V, Sears S, Woods J, Ling C Y, Hunt J, Clapper L M, Gaston B
Department of Pediatrics, Naval Medical Center.
J Pediatr. 1997 Mar;130(3):423-7. doi: 10.1016/s0022-3476(97)70204-x.
Expression of the inflammatory isoform of the enzyme nitric oxide synthase (NOS) is increased in airway-lining cells of patients with asthma. The NOS product nitric oxide (NO.) was measured in the expired gas of children with asthma. Vital capacity expirates from 21 control subjects and 13 subjects with asthma were assayed by chemiluminescence. Measurements were highly reproducible (coefficient of variation, 2.6% +/- 1.1%) and did not vary with age, sex, height, or weight. Patients with asthma had mean NO. levels (16.3 parts per billion) that were more than threefold higher than those of control subjects (5.05 ppb; p < 0.001). Expired NO. decreased as airflow obstruction improved during corticosteroid treatment (r2 = 0.77; n = 7; p < 0.001) but remained higher than normal (13.5 ppb; n = 5; p < 0.01) even after airflow obstruction resolved. We demonstrate the use of a reproducible test for asthma in children that is independent of measures of airflow obstruction. We speculate that expired NO assays may prove to be a more sensitive measure of childhood asthma than spirometry.
哮喘患者气道内衬细胞中炎症性一氧化氮合酶(NOS)的表达增加。对哮喘患儿呼出气体中的NOS产物一氧化氮(NO.)进行了测量。通过化学发光法对21名对照受试者和13名哮喘受试者的肺活量呼出气体进行了检测。测量结果具有高度可重复性(变异系数为2.6%±1.1%),且不随年龄、性别、身高或体重而变化。哮喘患者的平均NO.水平(十亿分之16.3)比对照受试者(5.05 ppb;p<0.001)高出三倍多。在皮质类固醇治疗期间,随着气流阻塞改善,呼出的NO.减少(r2 = 0.77;n = 7;p<0.001),但即使气流阻塞缓解后仍高于正常水平(13.5 ppb;n = 5;p<0.01)。我们展示了一种用于儿童哮喘的可重复性检测方法,该方法独立于气流阻塞的测量。我们推测,呼出NO检测可能被证明是比肺活量测定更敏感的儿童哮喘检测方法。